Japan Medical Dynamic Marketing, INC.JP:7600
| Mar 31,
2013 | Mar 31,
2014 | Mar 31,
2015 | Mar 31,
2016 | Mar 31,
2017 | Mar 31,
2018 | Mar 31,
2019 | Mar 31,
2020 | Mar 31,
2021 | Mar 31,
2022 | Mar 31,
2023 | Mar 31,
2024 |
|---|
| Profit (loss) before income taxes | -460 | 413 | 978 | 1,212 | 1,574 | 1,733 | 2,169 | 2,616 | 2,034 | 2,750 | 1,770 | 1,637 |
|---|
| Depreciation | 805 | 927 | 1,102 | 894 | 930 | 1,015 | 1,162 | 1,389 | 1,389 | 1,421 | 1,550 | 1,595 |
|---|
| Increase (decrease) in allowance for doubtful accounts | 6 | -39 | 2 | -1 | 0 | 1 | 0 | 0 | -11 | 0 | -0 | 3 |
|---|
| Increase (decrease) in retirement benefit liability | - | 22 | 30 | 37 | 50 | 43 | 53 | 71 | 64 | 60 | 47 | 80 |
|---|
| Remeasurements of defined benefit plans | - | - | 13 | 9 | 22 | 23 | 34 | 34 | 39 | 23 | 20 | 17 |
|---|
| Increase (decrease) in provision for bonuses | -13 | -1 | 47 | -10 | 13 | -14 | 11 | -2 | -2 | 21 | 3 | 41 |
|---|
| Increase (decrease) in provision for bonuses for directors (and other officers) | - | - | - | 31 | 30 | -10 | 7 | -8 | 3 | 11 | -1 | -37 |
|---|
| Increase (decrease) in provision for share awards for directors (and other officers) | - | - | - | - | - | - | 15 | 15 | 14 | 17 | 15 | 14 |
|---|
| Interest and dividend income | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
|---|
| Interest expenses | 90 | 142 | 149 | 136 | 117 | 124 | 104 | 81 | 41 | 30 | 18 | 32 |
|---|
| Commission for syndicate loan-trade-OpeCF | 61 | 23 | 32 | 27 | 11 | 12 | 13 | 6 | 9 | 7 | 9 | 10 |
|---|
| Foreign exchange losses (gains) | 7 | -10 | -26 | -2 | -10 | -22 | 9 | -8 | 7 | 56 | 74 | -24 |
|---|
| Share of loss (profit) of entities accounted for using equity method | - | - | - | - | - | - | - | - | - | 13 | 64 | 65 |
|---|
| Loss (gain) on sale and retirement of non-current assets | 68 | 62 | 109 | 324 | 174 | 45 | 39 | 35 | 37 | 87 | 60 | 49 |
|---|
| Loss (gain) on valuation of investment securities | - | - | - | - | - | - | - | - | - | - | - | 72 |
|---|
| Impairment losses | - | - | - | - | - | 187 | - | - | 54 | 0 | 0 | 0 |
|---|
| Provision for litigation settlement | - | - | - | - | - | - | - | - | - | - | 100 | - |
|---|
| Settlement-related costs | - | - | - | - | - | - | - | - | - | - | - | 75 |
|---|
| Loss on discontinued product | - | - | - | - | - | - | - | - | - | - | 143 | 10 |
|---|
| Increase (decrease) in provision for loss on business | - | - | - | - | - | - | - | - | - | 65 | -62 | -3 |
|---|
| Decrease (increase) in trade receivables | 321 | -425 | -866 | 104 | -581 | -484 | -136 | 118 | -31 | -662 | 11 | -438 |
|---|
| Decrease (increase) in inventories | 1,620 | -1,431 | 159 | -523 | -312 | 92 | -1,117 | -1,029 | -411 | -224 | -1,006 | -458 |
|---|
| Increase (decrease) in trade payables | -262 | 91 | 212 | -72 | -29 | 191 | 296 | -137 | -126 | 253 | 155 | 282 |
|---|
| Decrease (increase) in prepaid expenses | - | - | - | - | - | - | - | - | - | -16 | -95 | 73 |
|---|
| Increase/decrease in consumption taxes payable/consumption taxes refund receivable | -33 | -18 | 241 | -264 | 260 | -206 | 17 | 79 | 5 | 30 | -77 | 30 |
|---|
| Increase (decrease) in accounts payable - other | - | - | - | - | - | - | - | - | - | - | 44 | 45 |
|---|
| Other, net | -9 | -73 | 129 | 11 | 120 | 210 | -57 | -118 | -127 | -6 | -6 | 48 |
|---|
| Subtotal | 1,884 | -311 | 2,311 | 1,885 | 2,386 | 2,954 | 2,621 | 3,143 | 2,988 | 3,623 | 2,792 | 3,218 |
|---|
| Interest and dividends received | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Interest paid | -93 | -146 | -150 | -161 | -115 | -79 | -28 | -89 | -42 | -34 | -18 | -29 |
|---|
| Commission for syndicate loan-trade paid | -7 | -37 | -40 | -14 | -13 | -13 | -10 | -2 | -17 | -3 | -5 | -16 |
|---|
| Settlement-related costs paid | - | - | - | - | - | - | - | - | - | - | - | -175 |
|---|
| Income taxes refund (paid) | -137 | 37 | -154 | -143 | -220 | -300 | -215 | -322 | -329 | -474 | -583 | -893 |
|---|
| Net cash provided by (used in) operating activities | 1,648 | -457 | 1,968 | 1,567 | 2,038 | 2,563 | 2,367 | 2,731 | 2,600 | 3,112 | 2,186 | 2,105 |
|---|
| Purchase of property, plant and equipment | -1,571 | -1,313 | -1,052 | -1,572 | -1,056 | -1,001 | -1,978 | -1,654 | -1,348 | -1,538 | -1,222 | -1,783 |
|---|
| Purchase of intangible assets | -15 | -17 | -8 | -24 | -21 | -16 | -116 | -131 | -24 | -47 | -93 | -19 |
|---|
| Purchase of investment securities | - | - | - | - | - | - | - | - | - | - | -67 | - |
|---|
| Payments for investments in capital of subsidiaries and associates | - | - | - | - | - | - | - | - | - | -166 | -99 | - |
|---|
| Other, net | 0 | -3 | -2 | 0 | -1 | 1 | 1 | -4 | 1 | 1 | 0 | -2 |
|---|
| Net cash provided by (used in) investing activities | -1,576 | -1,330 | -1,059 | -1,592 | -1,078 | -1,016 | -2,093 | -1,789 | -1,345 | -1,750 | -1,482 | -1,805 |
|---|
| Net increase (decrease) in short-term borrowings | -1,678 | -57 | 268 | 460 | 934 | -499 | -984 | -1,160 | -575 | -369 | 501 | 144 |
|---|
| Repayments of long-term borrowings | -436 | -1,038 | -1,453 | -1,572 | -1,142 | -850 | -849 | -740 | -731 | -595 | -575 | -562 |
|---|
| Repayments of lease liabilities | -1 | -27 | -64 | -63 | -90 | -94 | -68 | -31 | -32 | -33 | -33 | -6 |
|---|
| Purchase of treasury shares | -0 | -0 | -0 | -0 | -52 | -0 | -0 | -35 | -0 | -0 | -91 | -0 |
|---|
| Purchase of treasury shares of subsidiaries | - | -49 | - | - | - | - | - | - | - | - | - | -73 |
|---|
| Dividends paid | -133 | -132 | -133 | -132 | -159 | -185 | -211 | -238 | -264 | -290 | -317 | -344 |
|---|
| Net cash provided by (used in) financing activities | -641 | 2,056 | -864 | -240 | -40 | -1,876 | -484 | -678 | -1,313 | -1,288 | -515 | -841 |
|---|
| Effect of exchange rate change on cash and cash equivalents | 29 | 32 | 42 | -4 | 3 | -6 | 13 | -12 | 13 | 51 | 25 | 57 |
|---|
| Net increase (decrease) in cash and cash equivalents | -540 | 301 | 87 | -268 | 923 | -335 | -196 | 251 | -47 | 125 | 214 | -483 |
|---|